Marker Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Marker Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Marker Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 8.9M shares, a 1.14% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 8.9M +100K +1.14% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 8.9M +100K +1.14% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 8.9M +100K +1.14% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 8.9M +500K +5.95% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 8.8M -74.8M -89.5% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 8.8M -74.8M -89.5% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 8.8M -74.7M -89.5% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 8.4M +100K +1.21% Dec 31, 2022 10-K 2024-03-26
Q3 2022 83.6M +500K +0.6% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 83.6M +500K +0.6% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 83.5M +500K +0.6% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 8.3M -42.4M -83.6% Dec 31, 2021 10-K 2023-03-22
Q3 2021 83.1M +35.1M +73.1% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 83.1M +36.5M +78.3% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 83M +36.5M +78.5% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 50.7M +5M +10.9% Dec 31, 2020 10-K 2022-03-17
Q3 2020 48M +2.3M +5.03% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 46.6M +1.1M +2.42% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 46.5M +1M +2.2% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 45.7M +300K +0.66% Dec 31, 2019 10-K 2021-03-09
Q3 2019 45.7M +31.9M +231% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 45.5M +31.9M +235% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 45.5M +34.9M +329% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 45.4M +34.8M +328% Dec 31, 2018 10-K 2020-03-12
Q3 2018 13.8M +3.3M +31.4% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 13.6M +3.44M +33.9% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 10.6M +2.13M +25.1% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 10.6M +2.2M +26.2% Dec 31, 2017 10-K 2019-03-15
Q3 2017 10.5M +2.1M +25.1% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 10.2M -61.3M -85.8% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 8.47M -62.5M -88.1% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 8.4M +2.52M +42.8% Dec 31, 2016 10-K 2018-03-23
Q3 2016 8.4M -54.5M -86.7% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 71.4M +33.4M +87.7% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 71M +38.4M +118% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 5.88M -14.4M -71% Dec 31, 2015 10-K 2017-03-14
Q3 2015 62.9M +43.3M +221% Sep 30, 2015 10-Q/A 2016-04-14
Q2 2015 38M +21.2M +126% Jun 30, 2015 10-Q/A 2016-04-14
Q1 2015 32.6M +16.8M +106% Mar 31, 2015 10-Q/A 2016-04-14
Q4 2014 20.3M +18.9M +1286% Dec 31, 2014 10-K 2016-04-14
Q3 2014 19.6M -125M -86.4% Sep 30, 2014 10-Q 2014-11-19
Q2 2014 16.8M Jun 30, 2014 10-Q 2014-08-18
Q1 2014 15.8M -99.7M -86.3% Mar 31, 2014 10-Q/A 2014-05-21
Q4 2013 1.47M +1 0% Dec 31, 2013 10-K 2015-04-15
Q3 2013 144M +70.4M +95.4% Sep 30, 2013 10-Q 2013-11-19
Q1 2013 116M +61.2M +113% Mar 31, 2013 10-Q 2013-08-19
Q4 2012 1.47M -50.6M -97.2% Dec 31, 2012 10-K/A 2014-04-17
Q3 2012 73.9M +26.5M +56% Sep 30, 2012 10-Q 2012-11-19
Q2 2012 54.3M +7.52M +16.1% Jun 30, 2012 10-Q/A 2012-09-12
Q1 2012 54.3M Mar 31, 2012 10-Q 2012-05-21
Q4 2011 52.1M +11.8M +29.4% Dec 31, 2011 10-Q 2012-11-19
Q3 2011 47.4M Sep 30, 2011 10-Q 2011-11-21
Q2 2011 46.8M Jun 30, 2011 10-Q 2011-08-22
Q4 2010 40.3M Dec 31, 2010 10-K 2012-04-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.